266 related articles for article (PubMed ID: 19171175)
1. Pneumococcal antibodies in a child with type 14 pneumococcal conjugate vaccine failure.
O'Brien KL; Moïsi J; Romero-Steiner S; Holder P; Carlone GM; Reid R; Santosham M
Vaccine; 2009 Mar; 27(12):1863-8. PubMed ID: 19171175
[TBL] [Abstract][Full Text] [Related]
2. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
[TBL] [Abstract][Full Text] [Related]
3. Predictors of pneumococcal conjugate vaccine immunogenicity among infants and toddlers in an American Indian PnCRM7 efficacy trial.
O'Brien KL; Moisi J; Moulton LH; Madore D; Eick A; Reid R; Weatherholtz R; Millar E; Hu D; Hackell J; Kohberger R; Siber G; Santosham M
J Infect Dis; 2007 Jul; 196(1):104-14. PubMed ID: 17538890
[TBL] [Abstract][Full Text] [Related]
4. Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children.
Henckaerts I; Durant N; De Grave D; Schuerman L; Poolman J
Vaccine; 2007 Mar; 25(13):2518-27. PubMed ID: 17034907
[TBL] [Abstract][Full Text] [Related]
5. Effect of community-wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age: a cross-sectional study in a high-risk population.
Millar EV; O'Brien KL; Watt JP; Bronsdon MA; Dallas J; Whitney CG; Reid R; Santosham M
Clin Infect Dis; 2006 Jul; 43(1):8-15. PubMed ID: 16758412
[TBL] [Abstract][Full Text] [Related]
6. Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial.
Ekström N; Väkeväinen M; Verho J; Kilpi T; Käyhty H
Infect Immun; 2007 Apr; 75(4):1794-800. PubMed ID: 17261612
[TBL] [Abstract][Full Text] [Related]
7. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B.
Saeland E; Jakobsen H; Ingolfsdottir G; Sigurdardottir ST; Jonsdottir I
J Infect Dis; 2001 Jan; 183(2):253-260. PubMed ID: 11110649
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449
[TBL] [Abstract][Full Text] [Related]
9. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
Soininen A; Nohynek H; Lucero M; Jousimies K; Ugpo J; Williams G; Käyhty H;
Vaccine; 2009 May; 27(20):2680-8. PubMed ID: 19428879
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
11. Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity.
Uddin S; Borrow R; Haeney MR; Moran A; Warrington R; Balmer P; Arkwright PD
Vaccine; 2006 Jul; 24(27-28):5637-44. PubMed ID: 16730399
[TBL] [Abstract][Full Text] [Related]
12. Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant.
Wuorimaa T; Dagan R; Väkeväinen M; Bailleux F; Haikala R; Yaich M; Eskola J; Käyhty H
J Infect Dis; 2001 Nov; 184(9):1211-5. PubMed ID: 11598848
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants.
Väkeväinen M; Eklund C; Eskola J; Käyhty H
J Infect Dis; 2001 Sep; 184(6):789-93. PubMed ID: 11517443
[TBL] [Abstract][Full Text] [Related]
14. The 23-valent pneumococcal polysaccharide vaccine does not provide additional serotype antibody protection in children who have been primed with two doses of heptavalent pneumococcal conjugate vaccine.
Balmer P; Borrow R; Arkwright PD
Vaccine; 2007 Aug; 25(34):6321-5. PubMed ID: 17629373
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers.
Goldblatt D; Southern J; Ashton L; Richmond P; Burbidge P; Tasevska J; Crowley-Luke A; Andrews N; Morris R; Borrow R; Cartwright K; Miller E
Pediatr Infect Dis J; 2006 Apr; 25(4):312-9. PubMed ID: 16567982
[TBL] [Abstract][Full Text] [Related]
16. Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vaccines in children and young adults with sickle cell disease.
Vernacchio L; Romero-Steiner S; Martinez JE; MacDonald K; Barnard S; Pilishvili T; Carlone GM; Ambrosino DM; Molrine DC
J Infect Dis; 2000 Mar; 181(3):1162-6. PubMed ID: 10720547
[TBL] [Abstract][Full Text] [Related]
17. A murine model for the study of immune memory in response to pneumococcal conjugate vaccination.
Moreno RL; Sampson JS; Romero-Steiner S; Wong B; Johnson SE; Ades E; Carlone GM
Vaccine; 2004 Aug; 22(23-24):3069-79. PubMed ID: 15297057
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial.
O'Brien KL; Moulton LH; Reid R; Weatherholtz R; Oski J; Brown L; Kumar G; Parkinson A; Hu D; Hackell J; Chang I; Kohberger R; Siber G; Santosham M
Lancet; 2003 Aug; 362(9381):355-61. PubMed ID: 12907008
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to serotype 9V exhibit novel serogroup cross-reactivity following infant pneumococcal immunization.
Licciardi PV; Balloch A; Russell FM; Mulholland EK; Tang ML
Vaccine; 2010 May; 28(22):3793-800. PubMed ID: 20362199
[TBL] [Abstract][Full Text] [Related]
20. Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.
Siber GR; Chang I; Baker S; Fernsten P; O'Brien KL; Santosham M; Klugman KP; Madhi SA; Paradiso P; Kohberger R
Vaccine; 2007 May; 25(19):3816-26. PubMed ID: 17368878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]